Cargando…

Valuation of Neutrophil/Lymphocyte Ratio in Renal Cell Carcinoma Grading and Progression

Introduction We investigated the association of the neutrophil/lymphocyte ratio (NLR) with tumor size and Fuhrman grade in nonmetastatic renal cell carcinoma (RCC) cases. Materials and methods Data of nonmetastatic RCC (T1-4N0M0) cases, operated between 2010 and 2016, were retrospectively reviewed a...

Descripción completa

Detalles Bibliográficos
Autores principales: Arda, Ersan, Yuksel, Ilkan, Cakiroglu, Basri, Akdeniz, Esra, Cilesiz, Nusret
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5844648/
https://www.ncbi.nlm.nih.gov/pubmed/29541572
http://dx.doi.org/10.7759/cureus.2051
_version_ 1783305275756773376
author Arda, Ersan
Yuksel, Ilkan
Cakiroglu, Basri
Akdeniz, Esra
Cilesiz, Nusret
author_facet Arda, Ersan
Yuksel, Ilkan
Cakiroglu, Basri
Akdeniz, Esra
Cilesiz, Nusret
author_sort Arda, Ersan
collection PubMed
description Introduction We investigated the association of the neutrophil/lymphocyte ratio (NLR) with tumor size and Fuhrman grade in nonmetastatic renal cell carcinoma (RCC) cases. Materials and methods Data of nonmetastatic RCC (T1-4N0M0) cases, operated between 2010 and 2016, were retrospectively reviewed and 103 patients were included in the study. The patients were divided into two groups according to tumor diameter (Group 1 T < 4 cm, Group 2 T ≥ 4 cm) and into three groups according to Fuhrman grade. Twenty-eight patients with a tumor diameter of 4 cm or less in Group 1 and 75 patients with a tumor diameter greater than 4 cm in Group 2 were compared. In both grouping systems, the NLR, mean platelet volume (MPV), red cell distribution width (RDW), white blood cell (WBC), red blood cell (RBC), platelet (PLT), lymphocyte, and neutrophil values and age were compared. Results There were no differences in age, MPV, RDW, neutrophil, WBC, RBC, PLT counts in groups of tumor diameter (Group 1 T < 4 cm, Group 2 T ≥ 4 cm). However, the lymphocyte amount was significantly higher in cases with a tumor diameter less than 4 cm compared to the cases with a tumor diameter greater than 4 cm (p = 0.015). It was observed that the NLR had a tendency to increase in patients with tumor size greater than 4 cm compared to patients with tumor size smaller than 4 cm (p = 0.029). There were no differences in age, MPV, RDW, lymphocyte, neutrophil, WBC, RBC, PLT counts, and the NLR in different Fuhrman-graded cases. Conclusions There is a linear relation between the tumor size and the NLR in nonmetastatic RCC cases. Therefore, the NLR is a cheap parameter that can be used to show the tumor size, and thus it can be used to get an idea about the prognosis of the patient.
format Online
Article
Text
id pubmed-5844648
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-58446482018-03-14 Valuation of Neutrophil/Lymphocyte Ratio in Renal Cell Carcinoma Grading and Progression Arda, Ersan Yuksel, Ilkan Cakiroglu, Basri Akdeniz, Esra Cilesiz, Nusret Cureus Urology Introduction We investigated the association of the neutrophil/lymphocyte ratio (NLR) with tumor size and Fuhrman grade in nonmetastatic renal cell carcinoma (RCC) cases. Materials and methods Data of nonmetastatic RCC (T1-4N0M0) cases, operated between 2010 and 2016, were retrospectively reviewed and 103 patients were included in the study. The patients were divided into two groups according to tumor diameter (Group 1 T < 4 cm, Group 2 T ≥ 4 cm) and into three groups according to Fuhrman grade. Twenty-eight patients with a tumor diameter of 4 cm or less in Group 1 and 75 patients with a tumor diameter greater than 4 cm in Group 2 were compared. In both grouping systems, the NLR, mean platelet volume (MPV), red cell distribution width (RDW), white blood cell (WBC), red blood cell (RBC), platelet (PLT), lymphocyte, and neutrophil values and age were compared. Results There were no differences in age, MPV, RDW, neutrophil, WBC, RBC, PLT counts in groups of tumor diameter (Group 1 T < 4 cm, Group 2 T ≥ 4 cm). However, the lymphocyte amount was significantly higher in cases with a tumor diameter less than 4 cm compared to the cases with a tumor diameter greater than 4 cm (p = 0.015). It was observed that the NLR had a tendency to increase in patients with tumor size greater than 4 cm compared to patients with tumor size smaller than 4 cm (p = 0.029). There were no differences in age, MPV, RDW, lymphocyte, neutrophil, WBC, RBC, PLT counts, and the NLR in different Fuhrman-graded cases. Conclusions There is a linear relation between the tumor size and the NLR in nonmetastatic RCC cases. Therefore, the NLR is a cheap parameter that can be used to show the tumor size, and thus it can be used to get an idea about the prognosis of the patient. Cureus 2018-01-10 /pmc/articles/PMC5844648/ /pubmed/29541572 http://dx.doi.org/10.7759/cureus.2051 Text en Copyright © 2018, Arda et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Urology
Arda, Ersan
Yuksel, Ilkan
Cakiroglu, Basri
Akdeniz, Esra
Cilesiz, Nusret
Valuation of Neutrophil/Lymphocyte Ratio in Renal Cell Carcinoma Grading and Progression
title Valuation of Neutrophil/Lymphocyte Ratio in Renal Cell Carcinoma Grading and Progression
title_full Valuation of Neutrophil/Lymphocyte Ratio in Renal Cell Carcinoma Grading and Progression
title_fullStr Valuation of Neutrophil/Lymphocyte Ratio in Renal Cell Carcinoma Grading and Progression
title_full_unstemmed Valuation of Neutrophil/Lymphocyte Ratio in Renal Cell Carcinoma Grading and Progression
title_short Valuation of Neutrophil/Lymphocyte Ratio in Renal Cell Carcinoma Grading and Progression
title_sort valuation of neutrophil/lymphocyte ratio in renal cell carcinoma grading and progression
topic Urology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5844648/
https://www.ncbi.nlm.nih.gov/pubmed/29541572
http://dx.doi.org/10.7759/cureus.2051
work_keys_str_mv AT ardaersan valuationofneutrophillymphocyteratioinrenalcellcarcinomagradingandprogression
AT yukselilkan valuationofneutrophillymphocyteratioinrenalcellcarcinomagradingandprogression
AT cakiroglubasri valuationofneutrophillymphocyteratioinrenalcellcarcinomagradingandprogression
AT akdenizesra valuationofneutrophillymphocyteratioinrenalcellcarcinomagradingandprogression
AT cilesiznusret valuationofneutrophillymphocyteratioinrenalcellcarcinomagradingandprogression